1. Global tuberculosis report 2021. Geneva: World Health organization. license: CC BY-NC-SA 3.0 IGO, 2021. Available: https://www.who.int/publications/digital/global-tuberculosis-report-2021/tb-disease-burden/incidence [Accessed 21 Oct 2021].
2. World Health Organization . WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2019.
3. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
4. Linezolid for drug-resistant pulmonary tuberculosis;Singh;Cochrane Database Syst Rev,2019
5. Conradie F , Everitt D , Olugbosi M . High rate of successful outcomes treating highly resistant TB in the ZeNix study of Pretomanid, bedaquiline, and alternative doses and durations of linezolid [Conference presentation]. IAS 2021, Berlin, Germany, 2021. Available: https://theprogramme.ias2021.org/Abstract/Abstract/2405 [Accessed 25 Sep 2021].